1 / 27

Blood and Lymphatic Infections

Blood and Lymphatic Infections. Chapter 28. A Diagram of the Circulatory System. Subacute Bacterial Endocarditis. Gram-Negative Septicemia. Causative agent Gram (-) bacteria more likely cause of fatal septicemia Shock is common despite treatment

Download Presentation

Blood and Lymphatic Infections

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Blood and Lymphatic Infections Chapter 28

  2. A Diagram of the Circulatory System

  3. Subacute Bacterial Endocarditis

  4. Gram-Negative Septicemia • Causative agent • Gram (-) bacteria more likely cause of fatal septicemia • Shock is common despite treatment • Mortality rate nearly 50% due to shock and lung damage • Blood cultures from patients usually reveal • E. coli • Ps. Aeruginosa • Bacteroidessp. • Symptoms • Violent shaking chills and fever • Often accompanied by anxiety and rapid breathing • In case of septic shock • Urine output drops • Respiration and pulse become more rapid • Arms and legs become cool and dusky colored

  5. Gram-Negative Septicemia • Pathogenesis • Generally originates outside of bloodstream • Endotoxin is released • Antibiotics can enhance endotoxin release • Exaggerated response Macrophage response to endotoxin • Failed localization allows endotoxin into bloodstream • Causes cascade of harmful events • Lungs particularly susceptible to irreversible damage • Often results in death despite successful treatment of infection

  6. Gram-Negative Septicemia • Epidemiology • Mainly a nosocomial disease • General trend • increased life span • antibiotic suppression of normal flora • use of immunosuppressive drugs • biofilm formation of medical devices • Prevention and Treatment • Identification and effective treatment of localized infections • Treatment against causative organisms

  7. Tularemia (Rabbit Fever) • Causative agent • Francisella tularensis • Non-motile, aerobic, Gram (-) rod • Symptoms • Characterized by development of skin ulcerations and enlargement of regional lymph nodes • Flu-like • Symptoms usually abate in 1 to 4 weeks • Sometimes may become chronic

  8. Tularemia (Rabbit Fever) • Pathogenesis: 90% of infected individuals survive in the absence of treatment • Causes ulcer at entry sight • Lymphatic vessels carry organism to regional lymph nodes • Become large, tender and filled with pus • Spread to other body sites via lymphatics and blood vessels • Pneumonia occurs in 10% - 15% of lung infections • Multiplies within phagocytes • Cell mediated immunity responsible for ridding infection

  9. Tularemia (Rabbit Fever) • Epidemiology • Occurs among wild animals in Northern Hemisphere • In eastern U.S. most infections occur in winter • Result from skinning hunted rabbits • In western U.S. infections increase in summer • Due to bites from fleas and ticks • Other reservoirs for infection include • Muskrats, beavers, squirrels, and deer • Prevention and Treatment • Uses PPE when working with animal carcasses • Insect repellents and protective clothing, inspect routinely for ticks • Vaccine available for workers at higher risk of exposure • Treated with gentamicin

  10. Brucellosis (Undulant Fever) • Causative agent • Four varieties of Brucella melitensis cause disease in humans • Traditionally each variety given own species name depending on preferred host • B. abortus  cattle • B. canis  dogs • B. melitensis  goats • B. suis  pigs • Organism is Gram (-) rod

  11. Brucellosis (Undulant Fever) • Symptoms • Onset usually gradual and symptoms vague • Symptoms flu-like • Without treatment most cases recover within 2 months • 15% will be symptomatic for 3 months or longer

  12. Brucellosis (Undulant Fever) • Pathogenesis • Organism penetrates mucous membranes or break in skin • Disseminated via lymphatic or blood vessels • Generally to heart , kidneys, and spleen • Organisms resistant to phagocytic killing • Mortality generally due to endocarditis • Rate is approximately 2% • Osteomyelitis is another serious side effect

  13. Brucellosis (Undulant Fever) • Epidemiology • Chronic infection of domestic food animals • Generally involving the mammary gland and uterus • Occurs in workers in meat packing industry • Prevention and Treatment • Pasteurization • Inspection of domestic animals • PPE when working with animals or animal carcass • Attenuated vaccine controls disease in domestic animals • Tetracycline combined with rifampin for 6 weeks

  14. Plague (Black Death) • Causative agent • Yersinia pestis • Facultative intracellular bacteria • Resemble safety pin in stained preparation

  15. Plague (Black Death) • Symptoms • Develop abruptly 1 – 6 days post infection • Transmission via bite from infected flea • Disease characterized by large tender lymph nodes called buboes • Other symptoms include • High fever • Shock • Delirium • Patchy bleeding under the skin • May also have cough and bloody sputum • Only in lungs infected • Pneumonic plague

  16. Plague (Black Death) • Pathogenesis • Flea regurgitates infected material into bite wound • Pla is essential to spread from site of entry • Organisms multiply within macrophages • Macrophages die and release organism • Inflammation in nodes results in characteristic swelling • Nodes become necrotic and spill organisms • Septicemic plague • Mortality rate of untreated reaches between 50% and 80%

  17. Plague (Black Death) • Epidemiology • Endemic on rodent populations in all continents except Australia • Prairie dogs, rock squirrels and their fleas are main reservoir • Can spread person to person by household fleas • Organism can remain viable for weeks in dried sputum and flea feces • Prevention and Treatment • Prevention directed by rat control • Killed vaccine gives short-term partial protection • Prompt diagnosis and treatment prevent high mortality • tetracycline for some exposed individuals to control epidemics • Gentamicin, ciprofloxacin and doxycycline effective if given early

  18. Infectious Mononucleosis • Causative agent • Caused by Epstein-Barr virus • Double-stranded DNA virus • Belongs to herpesvirus family • Symptoms • Appear after long incubation • Usually 30 to 60 days post infection • Symptoms include fever, sore throat covered with pus, fatigue, enlarged lymph nodes and spleen • Most cases fever and sore throat disappear within 2 weeks, lymph node enlargement within 3

  19. Pathogenesis of Epstein-Barr Virus

  20. Infectious Mononucleosis • Epidemiology • Distributed worldwide • Infects individuals in crowded, economically disadvantaged areas • Infects at early age without producing symptoms producing immunity • More affluent populations missed exposure and lack immunity • Virus present in saliva for up to 18 months • Mouth-to-mouth kissing important mode of transmission • No animal reservoir • Prevention and Treatment • Avoiding saliva of another person

  21. Yellow Fever • Causative agent • Enveloped, single-stranded RNA arbovirus • Belongs to flavivirus family • Virus multiplies in mosquitoes • Mosquitoes transmit virus to humans • Symptoms • Disease can range from mild to severe • Most common form may be only fever and slight headache lasting a day or two • Severe disease characterized by high fever, nausea, nose bleeds and bleeding into the skin, “black vomit” from GI bleeding and jaundice • Mortality rate of severe disease can reach 50% • Reason for the variation in symptoms is unknown

  22. Yellow Fever • Pathogenesis • Introduce via bite of Aedes mosquitoes • Multiplies and enters blood stream • Carried to liver • Jaundice results in liver damage • Injury to small blood vessels produces petechiae • Kidney failure is a common consequence of disease • Epidemiology • Reservoir mainly infected mosquitoes and primates in tropical regions of Central and South America and Africa • Periodically spread to urban areas via mosquito bite • Prevention and Treatment • Control achieved by spraying and elimination of breeding sites

  23. Malaria • Causative agent • Human malaria caused by four species of genus Plasmodium • P. vivax, P. falciparum, P. malatiae, P. ovale • Infectious form of parasite injected via mosquito • Carried by bloodstream to liver • Infects cells of liver • Thousands of offspring released to produce infection in erythrocytes

  24. Malaria • Symptoms • “flu-like” • Generally begin 2 weeks post infection • Transmission via bite of infected mosquito • Symptom pattern changes after 2 to 3 weeks • Falls into three categories • Cold phase – abruptly feels cold and develops shaking • Hot phase – follows cold phase • Temperature rises steeply reaching 104°F • Wet phase – follows hot phase • Temperature falls and drenching sweat occurs

  25. Malaria • Pathogenesis • Characteristic feature • Recurrent bouts of fever followed by times of wellness • Caused by erythrocytic cycle of growth and release of offspring • Spleen enlarges to cope with large amount of foreign material and abnormal RBC • Parasites cause anemia by destroying red RBC and converting iron from hemoglobin to non-usable form • Stimulates immune system • Overworked immune system fails and immunodeficiency develops

  26. Malaria • Epidemiology • Once common in both temperate and tropical areas • Now dominantly disease of warm climate • Eliminated from continental U.S. in late 1940’s • Mosquitoes of genus Anopheles are biological vectors • Infected mosquitoes and humans constitute reservoir • Transmission via mosquitoes, blood transfusion and sharing of syringes • Prevention and Treatment • Treatment is complicated • Chloroquine • Primaquine and tafenoquine

More Related